Agios Pharmaceuticals (8AP.F) Q2 2025 Earnings

1MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.62
3.89
9.4
14.9

Details

Expected EPS
-1.56761221514
Actual EPS
-1.372339
Surprise EPS
0.2
Surprise Percent
+12.46%

Description

Agios Pharmaceuticals (8AP.F) has reported earnings of -1.372339 per share for Q2 2025.

0 Comments

Share your thoughts